References
Anthony, L. B. (2013). Practical guide to supportive care of patients with functional neuroendocrine tumors. Seminars in Oncology, 40, 45-55. doi:10.1053/j.seminoncol.2012.11.002
Anthony, L. B., & Vinik, A. I. (2011). Evaluating the characteristics and the management of patients with neuroendocrine tumors receiving octreotide LAR during a 6 year period. Pancreas, 40, 987-994. doi:10.1097/MPA.0b013e31821f66b4
Bernheim, A. M., Connolly, H. M., Hobday, T. J., Abel, M. D., & Pellikka, P. A. (2007). Carcinoid heart disease. Progress in Cardiovascular Disease, 49, 439-451. doi:10.1016/j.pcad.2006.12.002
Bhattacharyya, S., Toumpanakis, C., Chilkunda, D., Caplin, M. E., & Davar, J. (2011). Risk factors for the development and progression of carcinoid heart disease. American Journal of Cardiology, 107, 1221-1226. doi:10.1016/j.amjcard.2010.12.025
Burke, A., Thomas, R., Elsayed, A., & Sobin, L. H. (1997). Carcinoids of the jejunum and ileum: An immunohistochemical and clinicopathologic study of 167 cases. Cancer, 79, 1086-1093. doi:10.1002/(SICI)1097-0142(19970315)79:6<1086::AID-CNCR5>3.0.CO;2-E
Castillo, J. G., Filsoufi, F., Rahmanian, P. B., Anyanwu, A., Zacks, J. S., Warner, R. R., & Adams, D. H. (2008). Early and late results of valvular surgery for carcinoid heart disease. Journal of the American College of Cardiology, 51, 1507-1509. doi:10.1016/j.jacc.2007.12.036
Chowsanitphon, J. (2010). Carcinoid tumor. Oncology Nursing Forum, 37, 677-679. doi:10.1188/10.ONF.677-679
Connolly, H. M., Nishimura, R. A., Smith, H. C., Pellikka, P. A., Mullany, C. J., & Kvols, L. K. (1995). Outcome of cardiac surgery for carcinoid heart disease. Journal of the American College of Cardiology, 25, 410-416. doi:10.1016/0735-1097 (94)00374-Y
Fox, F. J., & Khattar, R. S. (2004). Carcinoid heart disease: Presentation, diagnosis and management. Heart, 90, 1224-1228. doi:10.1136/hrt.2004.040329
Gardner-Roehnelt, N. M. (2012). Update on the management of neuroendocrine tumors: Focus on somatostatin antitumor effects. Clinical Journal of OncologyNursing, 16, 56-64. doi:10.1188/12.CJON.56-64
Gustafsson, B. I., Hauso, O., Drozdov, I., Kidd, I. M., & Modlin, M. (2008). Carcinoid heart disease. International Journal of Cardiology, 129, 318-324. doi:10.1016/j.ijcard.2008.02.019
Kulke, M. H., Benson, A. B., Bergsland, E., Berlin, J. D., Blaszkowsky, L. S., Choti, M. A., … Dwyer, M. A. (2012). Neuroendocrine tumors. Journal of the National Comprehensive Cancer Network, 10, 724-764.
Kulke, M. H., & Raut, C. P. (2008). Neuroendocrine tumors of the gastrointestinal tract. In D. P. Kelsen, J. M. Daly, S. E. Kern, B. Levin, J. E. Tepper, & E. Van Cutsem (Eds.), Principles and practice of gastrointestinal oncology (2nd ed., pp. 653-670). Philadelphia, PA: Lippincott Williams and Wilkins.
Lundin, L., Norheim, I., Landelius, J., Oberg, K., & Theodorsson-Norheim, E. (1988). Carcinoid heart disease: Relationship of circulating vasoactive substance to ultrasound-detectable cardiac abnormalities. Circulation, 77, 264-269.
Makridis, C., Oberg, K., Juhlin, C., Rastad, J., Johansson, H., Lorelius, L. E., & Akerstrom, G. (1990). Surgical treatment of mid-gut carcinoid tumors. World Journal of Surgery, 14, 377-383. doi:10.1007/BF01658532
Modlin, I. M., Lye, K. D., & Kidd, M. (2003). A 5-decade analysis of 13,715 carcinoid tumors. Cancer, 97, 934-959. doi:10.1002/cncr.11105
Oates, J. A., Melmon, K., Sjoerdsma, A., Gillespie, L., & Mason, D. T. (1964). Release of a kinin peptide in the carcinoid syndrome. Lancet, 1, 514-517. doi:10.1016/S0140-6736(64)92907-1
Pandya, U. H., Pellikka, P. A., Enriquez-Sarano, M., Edwards, W. D., Schaff, H. V., & Connolly, H. M. (2002). Metastatic carcinoid tumor to the heart: Echocardiographic-pathologic study of 11 patients. Journal of the American College of Cardiology, 40, 1328-1332. doi:10.1016/S0735-1097(02)02109-5
Patel, D., Moses, M., Escarcega, R., & Bove, A. A. (2014). Carcinoid heart disease: Current understanding and future directions. American Heart Journal, 167, 789-795. doi:10.1016/j.ahj.2014.03.018
Pellikka, P. A., Tajik, A. J., Khandheria, B. K., Seward, J. B., Callahan, J. A., Pitot, H. C., & Kvols, L. K. (1993). Carcinoid heart disease: Clinical and echocardiographic spectrum in 74 patients. Circulation, 87, 1188-1196. doi:10.1161/01.CIR.87.4.1188
Reichlin, S. (1983). Somatostatin. New England Journal of Medicine, 309, 1495-1501.
Rinke, A., Muller, H. H., Schade-Brittinger, C., Klose, K. J., Barth, P., Wied, M., … Arnold, R. (2009). Placebo-controlled, double blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: A report from the PROMID Study Group. Journal of Clinical Oncology, 27, 4656-4663. doi:10.1200/JCO.2009.22.8510
Scarsbrook, A. F., Ganeshan, A., Statham, J., Thakker, R. V., Weaver, A., Talbot, D., … Phillips, R. R. (2007). Anatomic and functional imaging of metastatic carcinoid tumors. Radiographics, 27, 455-477. doi:10.1148/rg.272065058
Strosberg, J. (2012). Neuroendocrine tumours of the small intestine. Best Practice and Research in Clinical Gastroenterology, 26, 755-773. doi:10.1016/j.bpg.2012.12.002